Amryt Pharma plc Holding(s) In Company
11 Dezembro 2020 - 7:00AM
UK Regulatory
TIDMAMYT
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible)(i)
----------------------------------------------------------------------------------------------------------
1a. Identity of the issuer or the underlying
issuer of existing shares to which
voting rights are attached(ii) : Amryt Pharma plc
------------------------------------------------ --------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
----------------------------------------------------------------------------------------------------------
Non-UK issuer
--------------------------------------------------------------------------------------- -----------------
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
----------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
--------------------------------------------------------------------------------------- -----------------
An acquisition or disposal of financial instruments X
--------------------------------------------------------------------------------------- -----------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------------- -----------------
Other (please specify)(iii) :
--------------------------------------------------------------------------------------- -----------------
3. Details of person subject to the notification obligation(iv)
Name Stonepine Capital Management, LLC
City and country of registered office
(if applicable) Bend, Oregon, USA
4. Full name of shareholder(s) (if different from 3.)(v)
----------------------------------------------------------------------------------------------------------
Name NA
------------------------------------------------ --------------------------------------------------------
City and country of registered office
(if applicable)
------------------------------------------------ --------------------------------------------------------
5. Date on which the threshold was
crossed or reached(vi) : 08/12/2020
------------------------------------------------ --------------------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 10/12/2020
------------------------------------------------ --------------------------------------------------------
7. Total positions of person(s) subject to the notification obligation
----------------------------------------------------------------------------------------------------------
% of voting rights
% of voting rights through financial Total number
attached to shares instruments (total Total of both of voting rights
(total of 8. A) of 8.B 1 + 8.B 2) in % (8.A + 8.B) of issuer(vii)
----------------------- ----------------------- ------------------ ----------------- -----------------
Resulting situation
on the date on
which threshold
was crossed or
reached NA 5.3% 5.3% 178,801,593
----------------------- ----------------------- ------------------ ----------------- -----------------
Position of previous NA NA NA
notification (if
applicable)
----------------------- ----------------------- ------------------ ----------------- -----------------
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached(viii)
--------------------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------------------------------
Class/type of
shares
ISIN code (if
possible) Number of voting rights(ix) % of voting rights
-------------------
Direct Indirect Indirect
(Art 9 of Directive (Art 10 of Directive Direct (Art 10 of Directive
2004/109/EC) 2004/109/EC) (Art 9 of Directive 2004/109/EC)
(DTR5.1) (DTR5.2.1) 2004/109/EC) (DTR5.1) (DTR5.2.1)
------------------ ---------------------- ------------------------ ----------------------------------- --------------------------
SUBTOTAL 8. A
------------------- ------------------------------------------------ ---------------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
--------------------------------------------------------------------------------------------------------------------------------------
Number of voting
rights that may be
acquired if the instrument
Type of financial Expiration Exercise/ is
instrument date(x) Conversion Period(xi) exercised/converted. % of voting rights
------------------- --------------------- ------------------------- ----------------------------------- --------------------------
ADS NA NA 9,402,010 5.3%
------------------- --------------------- ------------------------- ----------------------------------- --------------------------
SUBTOTAL 8. B 1 9,402,010 5.3%
------------------------- ----------------------------------- --------------------------
B 2: Financial Instruments with similar economic effect according to Art.
13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
--------------------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Physical or cash Number of % of voting rights
instrument date(x) Conversion settlement(xii) voting rights
Period (xi)
------------------ ---------------------- ------------------------ ----------------- --------------------------
SUBTOTAL 8.B.2
------------------------------------ --------------------------
9. Information in relation to the person subject to the notification obligation
(please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by
any natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held starting with the ultimate
controlling natural person or legal entity(xiv) (please add additional
rows as necessary) X
------------------------------------------------------------------------------------ -----------------------
% of voting rights
through financial
% of voting rights instruments if it Total of both if
if it equals or is equals or is higher it equals or is higher
higher than the notifiable than the notifiable than the notifiable
Name(xv) threshold threshold threshold
---------------------- -------------------------------- -------------------------- -----------------------
Jon M. Plexico NA 5.3% 5.3%
---------------------- -------------------------------- -------------------------- -----------------------
Stonepine Capital
Management, LLC NA 5.3% 5.3%
---------------------- -------------------------------- -------------------------- -----------------------
Timothy P. Lynch NA 5.3% 5.3%
---------------------- -------------------------------- -------------------------- -----------------------
Stonepine Capital
Management, LLC NA 5.3% 5.3%
---------------------- -------------------------------- -------------------------- -----------------------
10. In case of proxy voting, please identify:
-------------------------------------------------------------------------------------------------------------
Name of the proxy holder NA
-------------------------------------------------------- ---------------------------------------------------
The number and % of voting rights held
-------------------------------------------------------- ---------------------------------------------------
The date until which the voting rights
will be held
-------------------------------------------------------- ---------------------------------------------------
11. Additional information(xvi)
-------------------------------------------------------------------------------------------------------------
Place of completion Bend, Oregon, USA
------------------- -----------------
Date of completion 10/12/2020
------------------- -----------------
Annex: Notification of major holdings (to be filed with the FCA only)
-------------------------------------------------------------------------
A: Identity of the person subject to the notification obligation
-------------------------------------------------------------------------
Full name (including legal form for
legal entities)
-----------------------------------------------------------------------
Contact address (registered office
for legal entities)
-----------------------------------------------------------------------
E-Mail
-----------------------------------------------------------------------
Phone number / Fax number
-----------------------------------------------------------------------
Other useful information
(at least legal representative for
legal persons)
-----------------------------------------------------------------------
B: Identity of the notifier, if applicable
-------------------------------------------------------------------------
Full name
-----------------------------------------------------------------------
Contact address
-----------------------------------------------------------------------
E-Mail
-----------------------------------------------------------------------
Phone number / Fax number
-----------------------------------------------------------------------
Other useful information (e.g. functional
relationship with the person or legal
entity subject to the notification
obligation)
-----------------------------------------------------------------------
C: Additional information
-------------------------------------------------------------------------
Please send the completed form together with this annex to the FCA at
the following email
address: Majorshareholdings@fca.org.uk. Please send in Microsoft Word
format if possible.
(END) Dow Jones Newswires
December 11, 2020 05:00 ET (10:00 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Amryt Pharma (LSE:AMYT)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Amryt Pharma (LSE:AMYT)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
Notícias em tempo-real sobre Amryt Pharma Plc da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Amryt Pharma Plc
